Intervention Review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

  1. Ewa B Posner1,*,
  2. Khalid K Mohamed2,
  3. Anthony G Marson3

Editorial Group: Cochrane Epilepsy Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 2 FEB 2010

DOI: 10.1002/14651858.CD003032.pub2

Database Title

Additional Information

How to Cite

Posner EB, Mohamed KK, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003032. DOI: 10.1002/14651858.CD003032.pub2.

Author Information

  1. 1

    The Royal Victoria Infirmary, Department of Child Health, Newcastle-upon-Tyne, UK

  2. 2

    Royal Liverpool Childrens Hospital NHS Trust, Paediatric Neurology, Liverpool, UK

  3. 3

    Clinical Sciences Centre for Research & Education, University Department of Neurological Science, Liverpool, Merseyside, UK

*Ewa B Posner, Department of Child Health, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne, NE1 4LP, UK. e.b.posner@ncl.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 17 MAR 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (191K)Full (219K)

  1. Current Version

    Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

    Ewa B Posner, Khalid K Mohamed and Anthony G Marson

    Article first published online: 17 MAR 2010 | DOI: 10.1002/14651858.CD003032.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

    EB Posner, K Mohamed and AG Marson

    Article first published online: 20 JUL 2005 | DOI: 10.1002/14651858.CD003032

View Full Article (HTML) Summary (59K)Standard (191K)Full (219K)